Teleflex (NYSE:TFX) Releases FY 2026 Earnings Guidance

Teleflex (NYSE:TFX) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 6.250-6.550 for the period, compared to the consensus estimate of 15.180. The company issued revenue guidance of $2.3 billion-$2.3 billion, compared to the consensus revenue estimate of $3.7 billion.

Wall Street Analyst Weigh In

A number of analysts recently commented on TFX shares. Truist Financial boosted their price objective on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a report on Thursday, December 18th. Wells Fargo & Company decreased their price target on Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 29th. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $135.00 price objective on shares of Teleflex in a research note on Wednesday, December 17th. Needham & Company LLC lifted their price objective on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Wall Street Zen lowered Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Two equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $140.13.

Teleflex Stock Performance

NYSE:TFX opened at $119.19 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.57 and a quick ratio of 1.53. The firm has a market cap of $5.27 billion, a PE ratio of -16.22, a P/E/G ratio of 1.46 and a beta of 0.92. The firm has a 50 day simple moving average of $111.34 and a 200-day simple moving average of $118.68. Teleflex has a 1-year low of $100.18 and a 1-year high of $156.60.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th will be given a $0.34 dividend. The ex-dividend date of this dividend is Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. Teleflex’s payout ratio is currently -18.50%.

Teleflex News Roundup

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Board-approved multi-year restructuring tied to planned divestitures — the program is being viewed as a structural step to simplify the portfolio and accelerate value realization, which can support a recovery in the stock as assets are separated. Teleflex Launches Multi-Year Restructuring to Support Divestitures
• Positive Sentiment: Quarterly dividend declared ($0.34 per share) — the board’s cash return to shareholders signals commitment to returning capital during the transition, which can attract income-focused buyers. Teleflex Announces Quarterly Dividend
• Positive Sentiment: Market commentary and buy‑the‑dip flows — coverage pieces and investor writeups highlight the restructuring plus dividend as reasons to accumulate after the selloff, helping push the stock higher. Why Teleflex Incorporated’s (TFX) Stock Is Up 7.09%
• Neutral Sentiment: Management provided Q4 materials and a slide deck / earnings presentation — useful for investors parsing charge detail, cash flow implications, and the divestiture timeline before taking longer‑term positions. Teleflex Incorporated 2025 Q4 – Results – Earnings Call Presentation
• Negative Sentiment: Q4 results materially missed expectations — EPS and revenue fell well short of estimates (large EPS miss driven by charges and a steep 28.5% revenue decline year‑over‑year), which explains the prior selloff and remains a near‑term risk to sentiment. Teleflex (TFX) Q4 Earnings and Revenues Miss Estimates
• Negative Sentiment: FY‑2026 guidance was cut sharply (notably lower EPS and revenue targets vs. street consensus), reflecting expected headwinds and planned divestiture impacts — this raises execution risk and near-term earnings uncertainty despite the strategic plan. Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Empowered Funds LLC grew its holdings in Teleflex by 15.8% in the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after purchasing an additional 230 shares during the period. Jane Street Group LLC boosted its holdings in shares of Teleflex by 42.6% in the 1st quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock valued at $877,000 after purchasing an additional 1,895 shares during the last quarter. American Century Companies Inc. grew its stake in shares of Teleflex by 32.7% during the 2nd quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock valued at $1,614,000 after buying an additional 3,360 shares during the period. Invesco Ltd. increased its holdings in shares of Teleflex by 1.2% during the 2nd quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock worth $16,040,000 after buying an additional 1,659 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in shares of Teleflex by 108.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock worth $119,000 after buying an additional 521 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.